# Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

> **NCT02715024** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Taiwan, Inc.** · enrollment: 52 (actual)

## Conditions studied

- Lower Urinary Tract Symptoms
- Overactive Bladder
- Benign Prostatic Hyperplasia (BPH)

## Interventions

- **DRUG:** Tamsulosin
- **DRUG:** Solifenacin

## Key facts

- **NCT ID:** NCT02715024
- **Lead sponsor:** Astellas Pharma Taiwan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2016-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02715024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02715024, "Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02715024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*